CAR-T Therapy Market Report 2026
Download Free Sample Buy Now
CAR-T Therapy Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

CAR-T Therapy Market Report 2026

Global Outlook – By Type (Monotherapy, Combination Therapy), By Target Antigen (CD19, CD22, BCMA, Other Target Antigens), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

CAR-T Therapy Market Overview

• CAR-T Therapy market size has reached to $2.98 billion in 2025

• Expected to grow to $6.08 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%

• Growth Driver: Increasing Cancer Prevalence Driving Growth In The CAR-T Therapy Market

• Market Trend: Advancements in CAR-T Therapy: The Role of Diagnostic Tools in Enhancing Treatment Personalization and Patient Outcomes

• North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under CAR-T Therapy Market?

The chimeric antigen receptor-T therapy is a type of immunotherapy in which T-cells are taken from the patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as the chimeric antigen receptor (CAR), attaches to a specific protein in a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.

The main types of chimeric antigen receptor -T therapy is monotherapy and combination therapy. Monotherapy is used in the treatment of any disease with a single drug. The target antigens involved are CD19, CD22, and others that are used in various applications such as acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma, and others.

CAR-T Therapy market report bar graph

What Is The CAR-T Therapy Market Size and Share 2026?

The car-t therapy market size has grown rapidly in recent years. It will grow from $2.98 billion in 2025 to $3.45 billion in 2026 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to limited availability of personalized immunotherapy, high cost of early car-t treatments, dependence on hospital-based cell processing, nascent regulatory frameworks, low patient awareness of car-t therapy.

What Is The CAR-T Therapy Market Growth Forecast?

The car-t therapy market size is expected to see rapid growth in the next few years. It will grow to $6.08 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to technological advancements in t-cell engineering, growing investment in oncology research, expansion of commercial car-t manufacturing facilities, increasing regulatory approvals, rising collaborations between biopharma and academic institutions. Major trends in the forecast period include rising adoption of car-t therapies in hematologic malignancies, development of targeted antigen-specific car-t treatments, increasing use of combination therapy approaches, expansion of clinical trials and research programs, focus on reducing therapy costs and enhancing accessibility.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global CAR-T Therapy Market Segmentation

1) By Type: Monotherapy, Combination Therapy

2) By Target Antigen: CD19, CD22, BCMA, Other Target Antigens

3) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications

Subsegments:

1) By Monotherapy: CD19-targeted CAR-T Therapy, BCMA-Targeted CAR-T Therapy

2) By Combination Therapy: CAR-T Therapy With Immune Checkpoint Inhibitors, CAR-T Therapy With Other Targeted Therapies, CAR-T Therapy With Chemotherapy Or Radiotherapy

What Is The Driver Of The CAR-T Therapy Market?

The rising prevalence of cancer is expected to propel the growth of the CAR-T therapy market going forward. The rising prevalence of cancer refers to the increasing number of diagnosed cases of cancer within a specific population or region over a given period. The rising prevalence of cancer has driven research and investment in cancer therapies, including cellular immunotherapies. These treatments represent a significant advancement in the field of oncology and are particularly relevant for addressing the needs of cancer patients. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in In Australia, cancer diagnoses increased from 160,570 in 2022 to 164,694 in 2023, demonstrating a marked rise over the past year. This trend emphasizes the increasing prevalence of cancer across the nation. Therefore, the rising prevalence of cancer is driving the growth of the CAR-T therapy industry.

Key Players In The Global CAR-T Therapy Market

Major companies operating in the car-t therapy market are Gilead Sciences, Novartis AG, Biocon, Gracell Biotechnology Ltd., CARsgen Therapeutics, Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group, PersonGen Biomedicine, Hebei Senlang Biotech, Adaptimmune (UK), Autolus Therapeutics, BioNTech, Cellectis, Celyad, Immatics, Biocad, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Amgen, AstraZeneca, Merck, Pfizer, Juno Therapeutics, Allogene Therapeutics, Precision BioSciences, Bellicum, GlaxoSmithKline plc

Global CAR-T Therapy Market Trends and Insights

Major companies operating in the CAR-T therapy market are focusing on developing technologically advanced solutions such as diagnostic tools to enhance treatment personalization and improve patient outcomes. Diagnostic tools are instruments, devices, or software used to identify and analyze diseases, conditions, or health issues in individuals. These tools can include tests, imaging equipment, or lab analyses that provide insights into a patient's health status, aiding in accurate diagnosis and effective treatment planning. For instance, in February 2023, Eurofins Viracor, a US-based clinical diagnostic laboratory, launched the ExPeCT Expansion and Persistence of CAR T Assay to help clinicians better understand how CAR-T therapy is performing for their patients. offers significant benefits for monitoring patients undergoing CAR T cell therapy. First, it enables longitudinal tracking of CAR T cell expansion and persistence, providing real-time data that can inform treatment efficacy and patient management. Additionally, the assay helps identify patients at risk of treatment failure due to inadequate CAR T cell dynamics, allowing for timely interventions that could improve clinical outcomes in hematological malignancies.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The CAR-T Therapy Market?

In July 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, acquired Iveric Bio for $5.9 billion. With this acquisition, Astellas is better positioned to serve patients with ocular illnesses at high risk of going blind. The chance to establish a top-tier organization with Iveric Bio's ophthalmology knowledge and capabilities and Astellas' global resources is exceptional and has the potential to help patients worldwide who suffer from blinding retinal illnesses, including GA. The transaction was subject to Iveric Bio's stockholders' approval and other usual closing requirements, such as obtaining necessary regulatory approvals. Iveric Bio is a US-based Biotech company.

Regional Outlook

North America was the largest region in the CAR-T therapy market in 2025. Western Europe was the second-largest region in the global CAR-T therapy market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the CAR-T Therapy Market?

The chimeric antigen receptor -T therapy market includes revenues earned by CAR-T therapy products and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the CAR-T Therapy Market Report 2026?

The car-t therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the car-t therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

CAR-T Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.45 billion
Revenue Forecast In 2035 $6.08 billion
Growth Rate CAGR of 15.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Target Antigen, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Gilead Sciences, Novartis AG, Biocon, Gracell Biotechnology Ltd., CARsgen Therapeutics, Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group, PersonGen Biomedicine, Hebei Senlang Biotech, Adaptimmune (UK), Autolus Therapeutics, BioNTech, Cellectis, Celyad, Immatics, Biocad, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Amgen, AstraZeneca, Merck, Pfizer, Juno Therapeutics, Allogene Therapeutics, Precision BioSciences, Bellicum, GlaxoSmithKline plc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. CAR-T Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global CAR-T Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. CAR-T Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global CAR-T Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Car-T Therapies In Hematologic Malignancies

4.2.2 Development Of Targeted Antigen-Specific Car-T Treatments

4.2.3 Increasing Use Of Combination Therapy Approaches

4.2.4 Expansion Of Clinical Trials And Research Programs

4.2.5 Focus On Reducing Therapy Costs And Enhancing Accessibility

5. CAR-T Therapy Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Cancer Treatment Centers

5.3 Biopharmaceutical Companies

5.4 Research Institutions

5.5 Contract Research Organizations (Cros)

6. CAR-T Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global CAR-T Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global CAR-T Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global CAR-T Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global CAR-T Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global CAR-T Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global CAR-T Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. CAR-T Therapy Market Segmentation

9.1. Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monotherapy, Combination Therapy

9.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CD19, CD22, BCMA, Other Target Antigens

9.3. Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications

9.4. Global CAR-T Therapy Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CD19-targeted CAR-T Therapy, BCMA-Targeted CAR-T Therapy

9.5. Global CAR-T Therapy Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CAR-T Therapy With Immune Checkpoint Inhibitors, CAR-T Therapy With Other Targeted Therapies, CAR-T Therapy With Chemotherapy Or Radiotherapy

10. CAR-T Therapy Market Regional And Country Analysis

10.1. Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific CAR-T Therapy Market

11.1. Asia-Pacific CAR-T Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China CAR-T Therapy Market

12.1. China CAR-T Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India CAR-T Therapy Market

13.1. India CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan CAR-T Therapy Market

14.1. Japan CAR-T Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia CAR-T Therapy Market

15.1. Australia CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia CAR-T Therapy Market

16.1. Indonesia CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea CAR-T Therapy Market

17.1. South Korea CAR-T Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan CAR-T Therapy Market

18.1. Taiwan CAR-T Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia CAR-T Therapy Market

19.1. South East Asia CAR-T Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe CAR-T Therapy Market

20.1. Western Europe CAR-T Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK CAR-T Therapy Market

21.1. UK CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany CAR-T Therapy Market

22.1. Germany CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France CAR-T Therapy Market

23.1. France CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy CAR-T Therapy Market

24.1. Italy CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain CAR-T Therapy Market

25.1. Spain CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe CAR-T Therapy Market

26.1. Eastern Europe CAR-T Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia CAR-T Therapy Market

27.1. Russia CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America CAR-T Therapy Market

28.1. North America CAR-T Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA CAR-T Therapy Market

29.1. USA CAR-T Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada CAR-T Therapy Market

30.1. Canada CAR-T Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America CAR-T Therapy Market

31.1. South America CAR-T Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil CAR-T Therapy Market

32.1. Brazil CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East CAR-T Therapy Market

33.1. Middle East CAR-T Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa CAR-T Therapy Market

34.1. Africa CAR-T Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. CAR-T Therapy Market Regulatory and Investment Landscape

36. CAR-T Therapy Market Competitive Landscape And Company Profiles

36.1. CAR-T Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. CAR-T Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. CAR-T Therapy Market Company Profiles

36.3.1. Gilead Sciences Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Biocon Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Gracell Biotechnology Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. CARsgen Therapeutics Overview, Products and Services, Strategy and Financial Analysis

37. CAR-T Therapy Market Other Major And Innovative Companies

Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group, PersonGen Biomedicine, Hebei Senlang Biotech, Adaptimmune (UK), Autolus Therapeutics, BioNTech, Cellectis, Celyad, Immatics, Biocad, Celgene Corporation, Johnson & Johnson

38. Global CAR-T Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The CAR-T Therapy Market

40. CAR-T Therapy Market High Potential Countries, Segments and Strategies

40.1 CAR-T Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 CAR-T Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 CAR-T Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global CAR-T Therapy Market, Overview Of Key Products - Product Examples
  • Table 2: Global CAR-T Therapy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global CAR-T Therapy Market, Supply Chain Analysis
  • Table 4: Global CAR-T Therapy Market, Major Raw Material Providers
  • Table 5: Global CAR-T Therapy Market, Major Resource Providers
  • Table 6: Global CAR-T Therapy Market, Major Manufacturers (Suppliers)
  • Table 7: Global CAR-T Therapy Market, Major Distributors And Channel Partners
  • Table 8: Global CAR-T Therapy Market, Key Technologies & Future Trends
  • Table 9: Global CAR-T Therapy Market, Major Trends
  • Table 10: Global CAR-T Therapy Market, Major End Users
  • Table 11: Global CAR-T Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global CAR-T Therapy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global CAR-T Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global CAR-T Therapy Market - TAM, US$ Billion, 2025
  • Table 15: Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global CAR-T Therapy Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global CAR-T Therapy Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global CAR-T Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global CAR-T Therapy Market - Company Scoring Matrix
  • Table 96: Gilead Sciences Financial Performance
  • Table 97: Novartis AG Financial Performance
  • Table 98: Biocon Financial Performance
  • Table 99: Gracell Biotechnology Ltd. Financial Performance
  • Table 100: CARsgen Therapeutics Financial Performance
  • Table 101: Global CAR-T Therapy Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global CAR-T Therapy Market, Competitive Dashboard
  • Table 103: Global CAR-T Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, CAR-T Therapy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 105: Global, CAR-T Therapy Market Size Gain ($ Billion), Segmentation By Target Antigen, 2025 – 2030
  • Table 106: Global, CAR-T Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global CAR-T Therapy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global CAR-T Therapy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global CAR-T Therapy Market, Supply Chain Analysis
  • Figure 4: Global CAR-T Therapy Market, Major Raw Material Providers
  • Figure 5: Global CAR-T Therapy Market, Major Resource Providers
  • Figure 6: Global CAR-T Therapy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global CAR-T Therapy Market, Major Distributors And Channel Partners
  • Figure 8: Global CAR-T Therapy Market, Key Technologies & Future Trends
  • Figure 9: Global CAR-T Therapy Market, Major Trends
  • Figure 10: Global CAR-T Therapy Market, Major End Users
  • Figure 11: Global CAR-T Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global CAR-T Therapy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global CAR-T Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global CAR-T Therapy Market - TAM, US$ Billion, 2025
  • Figure 15: Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global CAR-T Therapy Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global CAR-T Therapy Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global CAR-T Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global CAR-T Therapy Market - Company Scoring Matrix
  • Figure 96: Gilead Sciences Financial Performance
  • Figure 97: Novartis AG Financial Performance
  • Figure 98: Biocon Financial Performance
  • Figure 99: Gracell Biotechnology Ltd. Financial Performance
  • Figure 100: CARsgen Therapeutics Financial Performance
  • Figure 101: Global CAR-T Therapy Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global CAR-T Therapy Market, Competitive Dashboard
  • Figure 103: Global CAR-T Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, CAR-T Therapy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 105: Global, CAR-T Therapy Market Size Gain ($ Billion), Segmentation By Target Antigen, 2025 – 2030
  • Figure 106: Global, CAR-T Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Read More About Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

The global medical gloves market report offers strategic insights and market intelligence through 2025.

Read More About The global medical gloves market report offers strategic insights and market intelligence through 2025.

Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Read More About Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Read More About Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

Read More About Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

Dialysis Devices And Equipment Market 2021 - By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By End-User (Hospitals And Clinics, Ambulator...

Joint Reconstruction Devices And Equipment Market 2021 - By Type (Knee Reconstruction Devices, Hip Reconstruction Devices, Extremity Reconstruction Devices), By Application (Arthrodesis, Arthroscopy, Joint Replacement Su...

COVID-19 Rapid Test Kits Market 2022 – By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Others), By Test Components (PCR Machines, Equipment And Extraction Kits, Reagents), By Specimen Type (Nasopharyn...

Wearable Blood Pressure Monitors Market - By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies - Global Forecast To 2030...

Pulse Oximeters and Spirometers Market - By Product Type (Pulse Oximeters, Spirometers), Type Of Device (Handheld, Fingertip), By Application (Diagnostic, Treatment Monitoring), By Patient Type (Asthma, COPD), By End-Use...

Sterilization Equipment And Disinfectants Market 2023 – By Product Type (Sterilization Equipment, Disinfectants), By Method (Physical Method, Chemical Method, Mechanical Method), By End Use (Hospitals And Clinics, Clinic...

Diagnostic Equipment Global Market Report 2022 – By Type (X-Ray Systems, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging Systems, Cardiovascular Monitoring And Diagnostic Devices, and Nu...

Methanol Market - By End Use (Formaldehyde, Mto/Mtp, Fuel Blending, Dimethyl Ether, Acetic Acid, Methyl Tert-Butyl Ether (Mtbe), Solvents, Methylamines, Mma, Chloro-Methanes), By Type Of Product( Plastics & Polymers, Chl...

Frequently Asked Questions

The CAR-T Therapy market was valued at $2.98 billion in 2025, increased to $3.45 billion in 2026, and is projected to reach $6.08 billion by 2030.

The global CAR-T Therapy market is expected to grow at a CAGR of 15.2% from 2026 to 2035 to reach $6.08 billion by 2035.

Some Key Players in the CAR-T Therapy market Include, Gilead Sciences, Novartis AG, Biocon, Gracell Biotechnology Ltd., CARsgen Therapeutics, Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group,

Major trend in this market includes: Advancements in CAR-T Therapy: The Role of Diagnostic Tools in Enhancing Treatment Personalization and Patient Outcomes . For further insights on this market. request a sample here

North America was the largest region in the CAR-T therapy market in 2025. Western Europe was the second-largest region in the global CAR-T therapy market share. The regions covered in the car-t therapy market report are Asia-Pacific, South E

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us